Concepedia

Author

Hidetoshi Nomoto

National Center for Global Health and MedicineORCID

Also Known As

H. Nomoto, H., Nomoto, Hidetoshi NOMOTO, Hidetoshi Nomoto, Keiji Nakamura

73

Publications

830

Citations

14

H-Index

25

Concepts

All Affiliations

National Center for Global Health and MedicineTohoku UniversityNational Institute of Infectious Diseases
HN

About

Hidetoshi Nomoto is an author at National Center for Global Health and Medicine specializing in medicine, infection control, and covid-19 epidemiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

326

2

Public Health

2

2

299

3

Epidemiology

2

2

299

4

Health Sciences

1

1

14

5

Global Health

1

1

195

Hidetoshi Nomoto

×

15

Publications

574

Citations

13

H-Index

YearCitations

Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan

Takahisa Fujino, Hidetoshi Nomoto, Satoshi Kutsuna,

Emerging infectious diseases

2021

195

Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19

Masaya Sugiyama, Noriko Kinoshita, Satoshi Ide,

Gene

2020

104

Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups in Japan

Yusuke Asai, Hidetoshi Nomoto, Kayoko Hayakawa,

Gerontology

2022

38

Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for <scp>COVID</scp>‐19

Daisuke Katagiri, Masahiro Ishikane, Yusuke Asai,

Journal of Clinical Apheresis

2020

36

Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020

Yuzo Arima, Satoshi Kutsuna, Tomoe Shimada,

Emerging infectious diseases

2020

34

SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine

Kayoko Hayakawa, Satoshi Kutsuna, Takeo Kawamata,

Global Health & Medicine

2020

27

Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers

Daisuke Katagiri, Masahiro Ishikane, Yusuke Asai,

Critical Care Explorations

2020

24

How we secured a <scp>COVID</scp>‐19 convalescent plasma procurement scheme in Japan

Mari Terada, Satoshi Kutsuna, Tomiteru Togano,

Transfusion

2021

23

Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission

Kei Yamamoto, Michiyo Suzuki, Gen Yamada,

International Journal of Infectious Diseases

2021

16

Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012–2013 and 2018–2019

Hidetoshi Nomoto, Masahiro Ishikane, Takato Nakamoto,

PLoS ONE

2020

14

Page 1